Artemis Medicare Services Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- ✓Attractively valued vs sector (P/E 40.3x vs industry 54.4x)
- ✓Low debt relative to equity (D/E 0.3x)
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,944 | ₹4.6L Cr | 37.3 | 5.59 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹7,388 | ₹1.9L Cr | 73.4 | 11.71 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹5,040 | ₹1.6L Cr | 73.6 | 20.32 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,939 | ₹1.3L Cr | 64.9 | 13.56 | 22.1 | 17.9 | 0.88 |
| CIPLA Cipla Limited | ₹1,416 | ₹1.1L Cr | 30.1 | 3.32 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,123 | ₹1.1L Cr | 21 | 4.17 | 21.2 | 21.1 | 0.38 |
| LUPIN Lupin Limited | ₹2,405 | ₹1.1L Cr | 19.6 | 4.9 | 28.7 | 29.9 | 0.32 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
ARTEMISMED · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 68.03% | 68.03% | 67.51% | 67.17% | 67.17% | 67.17% |
| FII | 0.11% | 0.10% | 0.16% | 0.21% | 0.65% | 0.31% |
| DII | 1.96% | 2.61% | 3.45% | 3.60% | 4.51% | 5.04% |
| Public | 22.72% | 22.08% | 21.76% | 21.93% | 20.59% | 20.39% |
| Govt | 7.18% | 7.18% | 7.12% | 7.09% | 7.09% | 7.09% |
Corporate Events
To consider and approve the Notice of the Postal Ballot for seeking the approval of Members of the Company for raising of funds
To consider and approve Audited Financial Results and recommendation of dividend, If any.
Dividend - Re 0.45 Per Share
Dividend - Rs 0.45 Per Share
Dividend - Re 0.45 Per Share
Latest News
All news →Artemis Medicare publishes notice for physical securities
*Artemis Medicare publishes notice for physical securities.* The company released a copy of a newspaper publication regarding the handling of physical securities. This is a routine corporate disclosure with no immediate financial impact. Such notices are typically issued for investor awareness and compliance purposes. 📊 *STOCKS:* ARTEMIS | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #CorporateFiling
Artemis Medicare publishes notice in newspaper
*Artemis Medicare publishes notice in newspaper* The company has released a copy of a newspaper publication as part of a regulatory requirement. **No financial figures or strategic updates** were disclosed. The filing is routine and does not indicate any immediate business change. 📊 *STOCKS:* ARTEMIS | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #corporate_filing
Artemis Medicare publishes notice in newspaper
*Artemis Medicare publishes notice in newspaper.* The company filed a copy of a newspaper publication with the NSE on June 23, 2026. This is a routine corporate disclosure with no immediate financial impact. Such notices are typically related to statutory requirements or shareholder communications. 📊 *STOCKS:* ARTEMIS | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #CorporateFiling
Artemis sets dividend record date for July 2026
*Artemis sets dividend record date for July 2026.* Artemis Medicare Services has set **10-Jul-2026** as the record date for dividend distribution. This date determines shareholders eligible for the upcoming dividend. The announcement follows standard corporate protocol ahead of payout. 📊 *STOCKS:* ARTEMIS | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #Dividend
Artemis Medicare announces corporate updates
*Artemis Medicare announces corporate updates* as per a filing on July 31, 2026. The company disclosed routine corporate information, though no financial figures or major strategic moves were revealed. The update appears to be administrative in nature. Investors await further clarity on future plans. 📊 *STOCKS:* ARTEMIS | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #corporateupdate
Artemis Medicare issues postal ballot notice
*Artemis Medicare issues postal ballot notice.* The company has published a notice for a postal ballot, indicating upcoming shareholder voting on key corporate matters. Such ballots typically relate to board reappointments, policy changes, or governance updates. No financial impact expected immediately. 📊 *STOCKS:* ARTEMIS | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #CorporateAction
Artemis Medicare calls shareholder meeting for postal ballot.
*Artemis Medicare calls shareholder meeting for postal ballot.* The company has issued a notice for a postal ballot, indicating key decisions may be put to vote. Such events typically precede corporate actions like amendments in charter or major policy changes. Shareholders must participate by the due date. 📊 *STOCKS:* ARTEMIS | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #ShareholderMeeting
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹272 Cr ▼1.1% | ₹275 Cr ▲7.8% | ₹255 Cr ▲6.3% | ₹240 Cr ▲3.4% | ₹232 Cr ▼3.7% | ₹241 Cr ▲8.1% | ₹223 Cr ▼0.9% | ₹225 Cr |
| Op. Profit | ₹45 Cr ▼11.8% | ₹51 Cr ▲24.4% | ₹41 Cr ▲13.9% | ₹36 Cr ▼2.7% | ₹37 Cr ▼11.9% | ₹42 Cr ▲16.7% | ₹36 Cr ▼5.3% | ₹38 Cr |
| OPM | 16.0% ▼11.1% | 18.0% ▲12.5% | 16.0% ▲6.7% | 15.0% ▼6.3% | 16.0% ▼11.1% | 18.0% ▲12.5% | 16.0% ▼5.9% | 17.0% |
| Net Profit | ₹22 Cr ▼26.7% | ₹30 Cr ▲42.9% | ₹21 Cr ▼8.7% | ₹23 Cr ▲9.5% | ₹21 Cr ▼4.5% | ₹22 Cr ▲29.4% | ₹17 Cr ▲21.4% | ₹14 Cr |
| EPS (₹) | 1.41 ▼34.7% | 2.16 ▲41.2% | 1.53 ▼8.4% | 1.67 ▲11.3% | 1.5 ▼7.4% | 1.62 ▲32.8% | 1.22 ▲17.3% | 1.04 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1.1K Cr ▲15.4% | ₹937 Cr ▲6.6% | ₹879 Cr ▲19.3% | ₹737 Cr ▲32.8% | ₹555 Cr ▲36.0% | ₹408 Cr ▼27.8% | ₹565 Cr ▲3.3% | ₹547 Cr |
| Expenses | ₹893 Cr ▲13.8% | ₹785 Cr ▲5.2% | ₹746 Cr ▲16.0% | ₹643 Cr ▲32.0% | ₹487 Cr ▲30.6% | ₹373 Cr ▼25.8% | ₹503 Cr ▲4.6% | ₹481 Cr |
| Op. Profit | ₹188 Cr ▲23.7% | ₹152 Cr ▲14.3% | ₹133 Cr ▲41.5% | ₹94 Cr ▲38.2% | ₹68 Cr ▲94.3% | ₹35 Cr ▼43.5% | ₹62 Cr ▼6.1% | ₹66 Cr |
| OPM | 17.0% ▲6.3% | 16.0% ▲6.7% | 15.0% ▲15.4% | 13.0% ▲8.3% | 12.0% ▲33.3% | 9.0% ▼18.2% | 11.0% ▼8.3% | 12.0% |
| Other Income | ₹27 Cr ▼18.2% | ₹33 Cr ▲371.4% | ₹7 Cr ▲0.0% | ₹7 Cr ▲133.3% | ₹3 Cr ▼57.1% | ₹7 Cr ▲75.0% | ₹4 Cr ▲100.0% | ₹2 Cr |
| Interest | ₹28 Cr ▼12.5% | ₹32 Cr ▲3.2% | ₹31 Cr ▲55.0% | ₹20 Cr ▲66.7% | ₹12 Cr ▼7.7% | ₹13 Cr ▲0.0% | ₹13 Cr ▲18.2% | ₹11 Cr |
| Depreciation | ₹48 Cr ▲6.7% | ₹45 Cr ▲12.5% | ₹40 Cr ▲29.0% | ₹31 Cr ▲40.9% | ₹22 Cr ▲0.0% | ₹22 Cr ▼4.3% | ₹23 Cr ▲15.0% | ₹20 Cr |
| PBT | ₹139 Cr ▲28.7% | ₹108 Cr ▲58.8% | ₹68 Cr ▲33.3% | ₹51 Cr ▲37.8% | ₹37 Cr ▲362.5% | ₹8 Cr ▼74.2% | ₹31 Cr ▼16.2% | ₹37 Cr |
| Tax % | 25.0% ▲4.2% | 24.0% ▼14.3% | 28.0% ▲12.0% | 25.0% ▲56.3% | 16.0% ▼11.1% | 18.0% ▼50.0% | 36.0% ▼20.0% | 45.0% |
| Net Profit | ₹104 Cr ▲26.8% | ₹82 Cr ▲67.3% | ₹49 Cr ▲28.9% | ₹38 Cr ▲22.6% | ₹31 Cr ▲416.7% | ₹6 Cr ▼68.4% | ₹19 Cr ▼5.0% | ₹20 Cr |
| EPS (₹) | 6.55 ▲9.2% | 6 ▲65.7% | 3.62 ▲25.7% | 2.88 ▲20.0% | 2.4 ▲389.8% | 0.49 ▼67.1% | 1.49 ▲53.6% | 0.97 |
| Div Payout | 7.0% ▲0.0% | 7.0% ▼41.7% | 12.0% ▼25.0% | 16.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Liabilities | |||||||||
| Equity Capital | ₹16 Cr ▲14.3% | ₹14 Cr ▲0.0% | ₹14 Cr ▲0.0% | ₹14 Cr ▲7.7% | ₹13 Cr ▲0.0% | ₹13 Cr ▲0.0% | ₹13 Cr ▲0.0% | ₹13 Cr ▲0.0% | ₹13 Cr |
| Reserves | ₹919 Cr ▲5.8% | ₹869 Cr ▲5.5% | ₹824 Cr ▲89.4% | ₹435 Cr ▲11.5% | ₹390 Cr ▲12.7% | ₹346 Cr ▲12.7% | ₹307 Cr ▲2.3% | ₹300 Cr ▲7.1% | ₹280 Cr |
| Borrowings | ₹262 Cr ▼6.1% | ₹279 Cr ▼3.8% | ₹290 Cr ▼9.4% | ₹320 Cr ▲11.9% | ₹286 Cr ▲42.3% | ₹201 Cr ▲36.7% | ₹147 Cr ▲30.1% | ₹113 Cr ▼0.9% | ₹114 Cr |
| Other Liabilities | ₹232 Cr ▼12.1% | ₹264 Cr ▲15.3% | ₹229 Cr ▲12.8% | ₹203 Cr ▼6.0% | ₹216 Cr ▲45.0% | ₹149 Cr ▲12.0% | ₹133 Cr ▼16.9% | ₹160 Cr ▲8.8% | ₹147 Cr |
| Total Liabilities | ₹1.4K Cr ▲0.2% | ₹1.4K Cr ▲5.1% | ₹1.4K Cr ▲39.6% | ₹972 Cr ▲7.4% | ₹905 Cr ▲27.5% | ₹710 Cr ▲18.3% | ₹600 Cr ▲2.4% | ₹586 Cr ▲5.8% | ₹554 Cr |
| Assets | |||||||||
| Fixed Assets | ₹805 Cr ▲1.4% | ₹794 Cr ▲6.6% | ₹745 Cr ▲3.6% | ₹719 Cr ▲18.8% | ₹605 Cr ▲23.7% | ₹489 Cr ▲27.7% | ₹383 Cr ▼2.5% | ₹393 Cr ▲3.1% | ₹381 Cr |
| CWIP | ₹28 Cr ▼20.0% | ₹35 Cr ▼12.5% | ₹40 Cr ▲21.2% | ₹33 Cr ▼65.3% | ₹95 Cr ▲48.4% | ₹64 Cr ▼21.0% | ₹81 Cr ▲44.6% | ₹56 Cr ▲14.3% | ₹49 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹596 Cr ▼0.2% | ₹597 Cr ▲4.4% | ₹572 Cr ▲161.2% | ₹219 Cr ▲6.8% | ₹205 Cr ▲30.6% | ₹157 Cr ▲15.4% | ₹136 Cr ▼0.7% | ₹137 Cr ▲10.5% | ₹124 Cr |
| Total Assets | ₹1.4K Cr ▲0.2% | ₹1.4K Cr ▲5.1% | ₹1.4K Cr ▲39.6% | ₹972 Cr ▲7.4% | ₹905 Cr ▲27.5% | ₹710 Cr ▲18.3% | ₹600 Cr ▲2.4% | ₹586 Cr ▲5.8% | ₹554 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating CF | ₹132 Cr ▼9.6% | ₹146 Cr ▲33.9% | ₹109 Cr ▼14.2% | ₹127 Cr ▲111.7% | ₹60 Cr ▲122.2% | ₹27 Cr ▼51.8% | ₹56 Cr ▲40.0% | ₹40 Cr |
| Investing CF | ₹-90 Cr ▲76.6% | ₹-385 Cr ▼337.5% | ₹-88 Cr ▲44.3% | ₹-158 Cr ▼47.7% | ₹-107 Cr ▼189.2% | ₹-37 Cr ▼42.3% | ₹-26 Cr ▲48.0% | ₹-50 Cr |
| Financing CF | ₹-50 Cr ▼118.7% | ₹267 Cr ▲1020.7% | ₹-29 Cr ▼176.3% | ₹38 Cr ▼13.6% | ₹44 Cr ▲144.4% | ₹18 Cr ▲166.7% | ₹-27 Cr ▼292.9% | ₹14 Cr |
| Net Cash Flow | ₹-8 Cr ▼129.6% | ₹27 Cr ▲437.5% | ₹-8 Cr ▼214.3% | ₹7 Cr ▲333.3% | ₹-3 Cr ▼137.5% | ₹8 Cr ▲300.0% | ₹2 Cr ▼60.0% | ₹5 Cr |
| Free Cash Flow | ₹32 Cr ▼41.8% | ₹55 Cr ▲48.6% | ₹37 Cr ▲305.6% | ₹-18 Cr ▲63.3% | ₹-49 Cr ▼1125.0% | ₹-4 Cr ▼113.3% | ₹30 Cr ▲276.5% | ₹-17 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 40d ▲2.6% | 39d ▲0.0% | 39d ▼15.2% | 46d ▼4.2% | 48d ▼2.0% | 49d ▲0.0% | 49d ▼5.8% | 52d |
| Inventory Days | — | — | — | — | — | — | — | — |
| Days Payable | — | — | — | — | — | — | — | — |
| Cash Conv. Cycle | 40d ▲2.6% | 39d ▲0.0% | 39d ▼15.2% | 46d ▼4.2% | 48d ▼2.0% | 49d ▲0.0% | 49d ▼5.8% | 52d |
| Working Capital Days | -17d ▲39.3% | -28d ▼3.7% | -27d ▲37.2% | -43d ▼65.4% | -26d ▲27.8% | -36d ▲0.0% | -36d ▲29.4% | -51d |
| ROCE | 15.0% ▲0.0% | 15.0% ▲7.1% | 14.0% ▲27.3% | 11.0% ▲10.0% | 10.0% ▲150.0% | 4.0% ▼60.0% | 10.0% | — |
Source: Screener.in · Lower days = better efficiency
About Artemis Medicare Services Limited
Artemis Medicare Services Ltd (AMSL) was incorporated in 2004, operates a 541-bedded multi-specialty tertiary care hospital in Gurgaon. [1][2]
Healthcare · Healthcare Services